trending Market Intelligence /marketintelligence/en/news-insights/trending/7npx_erhj5s5cbel5biiiw2 content esgSubNav
In This List

Predictive Technology acquires Regenerative Medical Technologies

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Predictive Technology acquires Regenerative Medical Technologies

Predictive Technology Group Inc. has acquired Regenerative Medical Technologies Inc., adding to the company's work in degenerative disc disease.

The deal covers the purchase of a stem cell product design, intellectual property, data and medical records, along with a clinical trial methodology for degenerative disc disease.

According to Salt Lake City-based Predictive Technology, lower back pain affects 266 million people globally, with degenerative disc disease being the most common cause.

Predictive Technology and its units focus on diagnostics for endometriosis, scoliosis, degenerative disc disease and other conditions.

Financial details for the acquisition were not disclosed.